Statistics
Publications
4
Citations
99
H-Index
4
Active since
2019
Affiliations
Zhengzhou University(Current)
Zhilu Ma is an author at Zhengzhou University specializing in oncology, molecular oncology, and pd-l1 blockade.
Publications per year
2019–2022
4
4
Discovery of WS-157 as a highly potent, selective and orally active EGFR inhibitor
Pengxing He, Sheng-Hui Niu, Shuai Wang et al. · Acta Pharmaceutica Sinica B · 2019 · 20 citations · Full text
Medicine, Oncology, Pharmacology +13
ATRA promotes PD-L1 expression to control gastric cancer immune surveillance
Zhilu Ma, Jing Jing, Linna Du et al. · European Journal of Pharmacology · 2022 · 11 citations
Medicine, Cancer Biology, Oncology +14
1–4 of 4